Search results for "Cirrhosis"
Urinary biomarker may help predict cirrhosis outcomes, study finds
Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2021/09/24/3.htm
24 Sep 2021
Spotlight on hepatitis A, B, and C
The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019
Spotlight on statin therapy
Studies published in May found a potential benefit of statin therapy for three different conditions.
https://gastroenterology.acponline.org/archives/2017/05/26/5.htm
26 May 2017
MKSAP quiz: New-onset ascites with lower-extremity edema
What is the most likely cause of this 68-year-old man's ascites?
https://gastroenterology.acponline.org/archives/2017/03/24/5.htm
24 Mar 2017
Noninvasive score for fibrotic NASH designed for, validated in primary care settings
Levels of aspartate aminotransferase, high-density lipoprotein cholesterol, and HbA1c can be used to predict which patients might need referral to a subspecialist for fibrotic nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2022/04/22/1.htm
22 Apr 2022
USPSTF recommends screening adults 18 to 79 years for hepatitis C virus infection with moderate certainty
An essential requirement of expanded screening is the availability of effective treatment, but randomized controlled trials to date have not shown clinical benefit of direct-acting antiviral therapy beyond sustained virologic response, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2020/07/24/7.htm
24 Jul 2020
Study identifies potential predictors of hospital-onset C. difficile infection
In patients colonized with Clostridioides difficile, risk factors for infection included longer length of stay, exposure to multiple classes of antibiotics, use of opioids, and cirrhosis, whereas use of laxatives was associated with a lower risk.
https://gastroenterology.acponline.org/archives/2019/07/26/8.htm
26 Jul 2019
In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy
Results from a French trial provide the best available evidence to justify using the expensive antibiotic in patients with hepatic encephalopathy associated with transjugular intrahepatic portosystemic shunt, according to an ACP Journal Club commentary.
https://gastroenterology.acponline.org/archives/2021/07/23/7.htm
23 Jul 2021
8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C
The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
https://gastroenterology.acponline.org/archives/2017/03/24/2.htm
24 Mar 2017
MKSAP Quiz: New-onset ascites
This month's quiz asks readers to determine appropriate management for a 55-year-old man with hepatitis C-related cirrhosis who is hospitalized for new-onset ascites.
https://gastroenterology.acponline.org/archives/2018/11/27/4.htm
27 Nov 2018